3-Hydroxyphencyclidine (3-HPC), a derivative of phencyclidine (PCP), is ever more attracting researcher attention due to limited data suggesting unique biological actions. Preliminary studies demonstrate that 3-HPC may exhibit distinct effects on the central structure, arguably playing a role to some of the unexpected symptoms related with PCP use.